STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On March 15, 2024, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register adding 2-methyl AP-237 to schedule I of the federal Controlled Substances Act. The scheduling action is effective April 15, 2024.
2. The Controlled Substances Board did not receive an objection to similarly listing 2-methyl AP-237 in schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing 2-methyl AP-237 as a schedule I controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rulemaking, listing 2-methyl AP-237 as a schedule I controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats 2-methyl AP-237 under chapter 961, Stats. by creating the following: CSB 2.003 Addition of 2-Methyl AP-237 to Schedule I. Section 961.14 (2) (qz), Stats., is created to read: 961.14 (2) (qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one).
This order shall become effective upon publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated _______________________
Doug Englebert, Chair
Controlled Substances Board
